loadpatents
name:-0.049283027648926
name:-0.03325891494751
name:-0.023108005523682
Marigo; Mauro Patent Filings

Marigo; Mauro

Patent Applications and Registrations

Patent applications and USPTO patent grants for Marigo; Mauro.The latest application filed is for "prodrugs of modulators of the nmda receptor".

Company Profile
25.37.50
  • Marigo; Mauro - Valby DK
  • Marigo; Mauro - Skovlunde DK
  • MARIGO; Mauro - Zurich CH
  • Marigo; Mauro - Tilst DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Prodrugs Of Modulators Of The Nmda Receptor
App 20220213117 - Kilburn; John Paul ;   et al.
2022-07-07
Prodrugs of modulators of the NMDA receptor
Grant 11,358,971 - Kilburn , et al. June 14, 2
2022-06-14
Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof
App 20220177557 - Pedersen; Jan Torleif ;   et al.
2022-06-09
New Compounds And Their Use As Therapeutically Active Substances In The Treatment And/or Prevention Of Diseases Involving The Retinal Pigment Epithelium
App 20220110921 - STEGER; Matthias ;   et al.
2022-04-14
Compounds For Use As Therapeutically Active Substances In The Treatment And/or Prevention Of Neuroretinal Diseases
App 20220089547 - STEGER; Matthias ;   et al.
2022-03-24
N-(4-(oxazol-5-yl)phenyl) Chromane-3-carboxamide Derivatives And Related Compounds As Stimulators Of The Production Of Retinal Precursor Cells For The Treatment Of Neuroretinal Diseases
App 20220089583 - STEGER; Matthias ;   et al.
2022-03-24
Antibodies specific for hyperphosphorylated tau and methods of use thereof
Grant 11,111,290 - Pedersen , et al. September 7, 2
2021-09-07
1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors
Grant 11,104,680 - Juhl , et al. August 31, 2
2021-08-31
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
Grant 11,026,923 - Kehler , et al. June 8, 2
2021-06-08
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
Grant 11,026,924 - Kehler , et al. June 8, 2
2021-06-08
Prodrugs Of Modulators Of The Nmda Receptor
App 20210047342 - Kilburn; John Paul ;   et al.
2021-02-18
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20210023056 - Kehler; Jan ;   et al.
2021-01-28
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20210015794 - Kehler; Jan ;   et al.
2021-01-21
Pyrazolo[3,4-b]pyridines And Imidazo[1,5-b]pyridazines As Pde1 Inhibitors
App 20210009571 - Kehler; Jan ;   et al.
2021-01-14
Modulators Of The Nmda Receptor
App 20210002292 - Kilburn; John Paul ;   et al.
2021-01-07
Combination Treatments Comprising Administration Of 1h-pyrazolo[4,3-b]pyridines
App 20200385372 - Kehler; Jan ;   et al.
2020-12-10
Combination Treatments Comprising Administration Of 1h-pyrazolo[4,3-b]pyridines
App 20200385381 - Kehler; Jan ;   et al.
2020-12-10
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20200375950 - Kehler; Jan ;   et al.
2020-12-03
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20200360343 - Kehler; Jan ;   et al.
2020-11-19
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
Grant 10,806,718 - Kehler , et al. October 20, 2
2020-10-20
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
Grant 10,766,893 - Juhl , et al. Sep
2020-09-08
Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors
Grant 10,689,379 - Kehler , et al.
2020-06-23
Antibodies specific for hyperphosphorylated tau and methods of use thereof
Grant 10,647,762 - Pedersen , et al.
2020-05-12
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20200129480 - Kehler; Jan ;   et al.
2020-04-30
Macrocycles as PDE1 inhibitors
Grant 10,618,913 - Juhl , et al.
2020-04-14
Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof
App 20200109192 - Pedersen; Jan Torleif ;   et al.
2020-04-09
1,5-dihydro-4h-pyrazolo[3,4-d]pyrimidin-4-ones And 1,5-dihydro-4h-pyrazolo[4,3-c]pyridin-4-ones As Pde1 Inhibitors
App 20200102316 - Juhl; Karsten ;   et al.
2020-04-02
2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridin- es as BACE1 inhibitors
Grant 10,603,310 - Juhl , et al.
2020-03-31
1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitors
Grant 10,538,525 - Juhl , et al. Ja
2020-01-21
1 H-pyrazolo[4,3-B]pyridines as PDE1 inhibitors
Grant 10,512,632 - Kehler , et al. Dec
2019-12-24
Antibodies specific for hyperphosphorylated tau and methods of use thereof
Grant 10,487,142 - Pedersen , et al. Nov
2019-11-26
Pyrazolo[3,4-b]pyridines And Imidazo[1,5-b]pyridazines As Pde1 Inhibitors
App 20190352302 - Kehler; Jan ;   et al.
2019-11-21
Antibodies specific for hyperphosphorylated tau and methods of use
Grant 10,472,415 - Pedersen , et al. Nov
2019-11-12
Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof
App 20190284266 - Pedersen; Jan Torleif ;   et al.
2019-09-19
Antibodies Specific For Hyperphosphorylated Tau And Methods Of Use Thereof
App 20190284265 - Pedersen; Jan Torleif ;   et al.
2019-09-19
Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as PDE1 inhibitors
Grant 10,351,561 - Kehler , et al. July 16, 2
2019-07-16
1,5-dihydro-4h-pyrazolo[3,4-d]pyrimidin-4-ones And 1,5-dihydro-4h-pyrazolo[4,3-c]pyridin-4-ones As Pde1 Inhibitors
App 20190194204 - Juhl; Karsten ;   et al.
2019-06-27
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20190194189 - Juhl; Karsten ;   et al.
2019-06-27
Macrocycles As Pde1 Inhibitors
App 20190185489 - Juhl; Karsten ;   et al.
2019-06-20
1h-pyrazolo[4,3-b]pyridines As Pde1 Inhibitors
App 20190105302 - Kehler; Jan ;   et al.
2019-04-11
2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridin- Es As Bace1 Inhibitors
App 20190000823 - Juhl; Karsten ;   et al.
2019-01-03
2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyri- Dines As Bace1 Inhibitors
App 20180244645 - JUHL; Karsten ;   et al.
2018-08-30
2-amino-5,5-difluoro-6-(fluoromethyl)-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors
Grant 10,058,540 - Juhl , et al. August 28, 2
2018-08-28
2-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treating alzheimer's disease
Grant 10,059,669 - Juhl , et al. August 28, 2
2018-08-28
2-amino-7a-phenyl-3,4,4a,5,7,7a-hexahydrofuro[3,4-b]pyridines As Bace1 Inhibitors
App 20180230160 - Juhl; Karsten ;   et al.
2018-08-16
2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridin- es as BACE1 inhibitors
Grant 10,045,974 - Juhl , et al. August 14, 2
2018-08-14
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
Grant 10,034,861 - Kehler , et al. July 31, 2
2018-07-31
6-amino-5-fluoro-5-(fluoromethyl)-2,3,4,5-tetrahydropyridin-2-yl-phenyl-5-- (methoxy-d3)-pyrazine-2-carboxamides And Fluorinated Derivatives Thereof As Bace1 Inhibitors
App 20180186769 - Juhl; Karsten ;   et al.
2018-07-05
2-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyri- dines as BACE1 inhibitors
Grant 10,011,596 - Juhl , et al. July 3, 2
2018-07-03
PYRAZOLO[3,4-b]PYRIDINES AND IMIDAZO[1,5-b]PYRIDAZINES AS PDE1 INHIBITORS
App 20180179200 - Kehler; Jan ;   et al.
2018-06-28
Combination treatment comprising administration of 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines
Grant 10,004,738 - Juhl , et al. June 26, 2
2018-06-26
Antibodies Specific for Hyperphosphorylated Tau and Methods of Use Thereof
App 20180016330 - Pedersen; Jan Torleif ;   et al.
2018-01-18
1H-Pyrazolo[4,3-b]pyridines as PDE1 Inhibitors
App 20180000786 - Kehler; Jan ;   et al.
2018-01-04
2-Amino-5,5-Difluoro-6-(Fluoromethyl)-6-Phenyl-3,4,5,6-Tetrahydropyridines as BACE1 Inhibitors
App 20170340618 - Juhl; Karsten ;   et al.
2017-11-30
2-Amino-6-(Difluoromethyl)-5,5-Difluoro-6-Phenyl-3,4,5,6-Tetrahydropyridin- es as BACE1 Inhibitors
App 20170319564 - Juhl; Karsten ;   et al.
2017-11-09
2-Amino-3,5-Difluoro-3,6-Dimethyl-6-Phenyl-3,4,5,6-Tetrahydropyridines as BACE1 Inhibitors for Treating Alzheimer's Disease
App 20170313658 - JUHL; Karsten ;   et al.
2017-11-02
1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 Inhibitors
App 20170291901 - Juhl; Karsten ;   et al.
2017-10-12
Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors
Grant 9,669,029 - Puschl , et al. June 6, 2
2017-06-06
2-Amino-3,5,5-Trifluoro-3,4,5,6-Tetrahydropyridines as BACE1 Inhibitors for Treatment of Alzheimer's Disease
App 20170066741 - Juhl; Karsten ;   et al.
2017-03-09
2-Amino-3-Fluoro-3-(Fluoromethyl)-6-Methyl-6-Phenyl-3,4,5,6-Tetrahydropyri- dines as BACE1 Inhibitors
App 20170044151 - Juhl; Karsten ;   et al.
2017-02-16
Combination Treatment Comprising Administration of 2-Amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines
App 20170042895 - Juhl; Karsten ;   et al.
2017-02-16
2-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's disease
Grant 9,353,084 - Juhl , et al. May 31, 2
2016-05-31
2-amino 6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridin- es as BACE1 inhibitors
Grant 9,346,797 - Juhl , et al. May 24, 2
2016-05-24
2-Amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridin- es as BACE1 Inhibitors
App 20160130267 - Juhl; Karsten ;   et al.
2016-05-12
Heteroaromatic Phenylimidazole derivatives as PDE10A enzyme inhibitors
App 20150290191 - Puschl; Ask ;   et al.
2015-10-15
2-Amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's disease
App 20150232449 - Juhl; Karsten ;   et al.
2015-08-20
Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors
Grant 9,096,589 - Puschl , et al. August 4, 2
2015-08-04
Substituted imidazo[2,1-A]isoindoles as PDE10 inhibitors
Grant 9,062,060 - Kehler , et al. June 23, 2
2015-06-23
2-arylimidazole derivatives as PDE10A enzyme inhibitors
Grant 8,927,738 - Puschl , et al. January 6, 2
2015-01-06
Imidazole derivatives as PDE10 enzyme inhibitors
App 20140357639 - Kehler; Jan ;   et al.
2014-12-04
Tricyclic imidazole compounds as PDE10 inhibitors
Grant 8,796,304 - Kehler , et al. August 5, 2
2014-08-05
(3-aryl-1H-1,2,4-triazol-5-yl)-linked heterocycle derivatives
Grant 8,785,653 - Puschl , et al. July 22, 2
2014-07-22
Tricyclic imidazole compounds as PDE10 inhibitors
App 20140005201 - Kehler; Jan ;   et al.
2014-01-02
2-arylimidazole Derivatives As Pde10a Enzyme Inhibitors
App 20130289038 - Puschl; Ask ;   et al.
2013-10-31
Heteroaromatic Aryl Triazole Derivatives as PDE10A Enzyme Inhibitors
App 20130281459 - Puschl; Ask ;   et al.
2013-10-24
Tricyclic imidazole compounds as PDE10 inhibitors
Grant 8,552,045 - Kehler , et al. October 8, 2
2013-10-08
(3-aryl-1H-1,2,4-triazol-5-yl)-linked heterocycle derivatives
Grant 8,501,795 - Puschl , et al. August 6, 2
2013-08-06
(2-aryl-1H-imidazol-4-yl)-linked heterocycle derivatives
Grant 8,501,797 - Puschl , et al. August 6, 2
2013-08-06
Heteroaromatic Phenylimidazole derivatives as PDE10A enzyme inhibitors
App 20120309714 - Puschl; Ask ;   et al.
2012-12-06
Heteroaromatic aryl triazole derivatives as PDE10A enzyme inhibitors
App 20120309764 - Puschl; Ask ;   et al.
2012-12-06
2-arylimidazole Derivatives As Pde10a Enzyme Inhibitors
App 20120302548 - Puschl; Ask ;   et al.
2012-11-29
Imidazole derivatives as PDE10A enzyme inhibitors
App 20120129836 - Kehler; Jan ;   et al.
2012-05-24
Catalytic Asymmetric Synthesis of Optically Active Alpha-Halo-Carbonyl Compounds
App 20070276142 - Halland; Nis ;   et al.
2007-11-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed